Brief: Cortexyme Presents New Data Demonstrating Evidence Of P. Gingivalis Infection Of The Central Nervous System In Alzheimer's Disease
Aug 25 (Reuters) - Cortexyme Inc CRTX.O :
* CORTEXYME PRESENTS NEW DATA DEMONSTRATING EVIDENCE OF P.
GINGIVALIS INFECTION OF THE CENTRAL NERVOUS SYSTEM IN
ALZHEIMER’S DISEASE AT ANNUAL BIOMARKERS FOR ALZHEIMER’S DISEASE
SUMMIT
Source text for Eikon: ID:nBw7kPrqsa
Further company coverage: CRTX.O
(((Reuters.Briefs@thomsonreuters.com);))
Recent news on IRulya Therapeutics
See all newsBrief: Quince Therapeutics - Changes Name To Irulya Therapeutics
Brief: Quince Therapeutics - Appoints Brigette Roberts As CEO Effective October 8, 2026
Quince Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Quince Therapeutics Reports Second Quarter 2026 Financial Results And Corporate Update
Quince Therapeutics Q2 net loss widens on acquisition charges